Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 320 participants.
Also called NCT05677100
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 320 participants
- Sponsor
- Procyrion
- Registry
-
NCT05677100
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Hungary
- Registry status
- Recruiting
Technical summary
Registry record NCT05677100. Randomized; no masking; primary purpose treatment. Start 2023-08-23 (actual); primary completion 2028-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
- Acronym
- DRAIN-HF
- Condition
- Heart Failure
- Condition
- Cardiorenal Syndrome
- Condition
- Cardio-Renal Syndrome
- Condition
- ADHF
- Condition
- Heart Failure, Systolic
- Condition
- Heart Failure, Diastolic
- Condition
- Heart Failure; With Decompensation
- Condition
- Heart Failure, Congestive
- Intervention (Device)
- Aortix System
- Lead sponsor
- Procyrion
Record details
- Record id
cardio:ct-nct05677100- Content hash
94aa936298fb66421f2a7ccca4f3cf9eadfbd1d7cab97faf5e0329729b423e99